EffieWPetersdorfMD

Professor, Medicine, University of Washington School of Medicine

Are you Dr. Petersdorf?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 94 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Effie Petersdorf, MD is a hematologist in Seattle, Washington. She is currently licensed to practice medicine in Washington. She is affiliated with Fred Hutch Cancer Center and UW Medicine/University of Washington Medical Center.

University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1988
University of WashingtonResidency, Internal Medicine, 1982 - 1985
McGill University Faculty of MedicineClass of 1982

PubMed

940 citations
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Stephanie J. Lee, John P. Klein, Michael Haagenson, Lee Ann Baxter-Lowe, Dennis L. Confer
Blood. 2007-12-15
204 citations
High HLA-DP Expression and Graft-versus-Host Disease.
Effie W. Petersdorf, Mari Malkki, Colm O'hUigin, Mary Carrington, Ted Gooley
The New England Journal of Medicine. 2015-08-12
376 citations
Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient
Effie W. Petersdorf, Ted Gooley, Claudio Anasetti, Paul J. Martin, Anajane G. Smith
Blood. 1998-11-15

Dr. Fred Appelbaum Receives Lifetime Achievement AwardFebruary 20th, 2023
New Genetic Clues to Why Most Bone Marrow Transplant Patients Develop Graft-Versus-Host DiseaseSeptember 4th, 2012

Clinical Significance Of MHC Haplotypes In HCTNational Cancer Institute2003–2012
Genetic Mechanisms Of Survivorship Disparities After Unrelated HCTNational Cancer Institute2011
Hematopoietic Stem Cell And Cord Blood TransplantationNational Institute Of Allergy And Infectious Diseases2010–2011
Immunogenetics Of Graft-Versus-Host DiseaseNational Cancer Institute2007–2011
Hematopopietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2006–2009
Clinical Significance Of MHC Haplotypes In Hematopoietic Cell TransplantationNational Cancer Institute2007
Hematopoietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005
SNPS In Lung Cancer Risk And Therapeutic ResponseNational Cancer Institute2003–2004
Optimizing BMT For Cancer By Genetic Matching Of DonorsNational Cancer Institute1997–2003
Immune Deviation Or Tolerance Induced By Human Lymphoid DendriticNational Institute Of Allergy And Infectious Diseases2002
Functional Genomic Markers In Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2002
Identification Of Peptide Ligands Responsible For GVHDNational Institute Of Allergy And Infectious Diseases1996–1999